ARTICLEhttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/3/article-p225.xmlMolecular Diagnostics: Another Battle Brewing2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/3/article-p225.pdf2026-04-18Molecular Diagnostics: Another Battle Brewinghttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/3/article-pxviii.xmlNCCN News2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/3/article-pxviii.pdf2026-04-18NCCN Newshttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/3/article-pxxxiii.xmlOncology Research Program2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/3/article-pxxxiii.pdf2026-04-18Oncology Research Programhttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/3/article-p257.xmlClinical and Genetic Risk Factors for Adverse Metabolic Outcomes in North American Testicular Cancer Survivors2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/3/article-p257.pdf2026-04-18Clinical and Genetic Risk Factors for Adverse Metabolic Outcomes in North American Testicular Cancer Survivorshttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/3/article-p245.xmlNCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.20182026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/3/article-p245.pdf2026-04-18NCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018https://harbor.dev.pubfactory.com/view/journals/jnccn/16/3/article-p238.xmlA Novel PRKAR1B-BRAF Fusion in Gastrointestinal Stromal Tumor Guides Adjuvant Treatment Decision-Making During Pregnancy2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/3/article-p238.pdf2026-04-18A Novel PRKAR1B-BRAF Fusion in Gastrointestinal Stromal Tumor Guides Adjuvant Treatment Decision-Making During Pregnancyhttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/3/article-p230.xmlIdelalisib and Rituximab in 17p Deletion–Positive Splenic Marginal Zone Lymphoma2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/3/article-p230.pdf2026-04-18Idelalisib and Rituximab in 17p Deletion–Positive Splenic Marginal Zone Lymphomahttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/3/article-p226.xmlLetter to the Editor: No Evidence to Promote Interim FDG-PET Adapted Therapy in the NCCN Guidelines for Hodgkin Lymphoma2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/3/article-p226.pdf2026-04-18Letter to the Editor: No Evidence to Promote Interim FDG-PET Adapted Therapy in the NCCN Guidelines for Hodgkin Lymphomahttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/3/article-p323.xmlGenomic Testing in Lung Cancer: Past, Present, and Future2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/3/article-p323.pdf2026-04-18Genomic Testing in Lung Cancer: Past, Present, and Futurehttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/3/article-p310.xmlBreast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/3/article-p310.pdf2026-04-18Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncologyhttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/3/article-p301.xmlCommunity Oncologists' Decision-Making for Treatment of Older Patients With Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/3/article-p301.pdf2026-04-18Community Oncologists' Decision-Making for Treatment of Older Patients With Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/3/article-p294.xmlTen-Year Trends in Antiemetic Prescribing in Patients Receiving Highly Emetogenic Chemotherapy2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/3/article-p294.pdf2026-04-18Ten-Year Trends in Antiemetic Prescribing in Patients Receiving Highly Emetogenic Chemotherapyhttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/3/article-p275.xmlAdherence to the World Cancer Research Fund/American Institute for Cancer Research Guideline Is Associated With Better Health-Related Quality of Life Among Chinese Patients With Breast Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/3/article-p275.pdf2026-04-18Adherence to the World Cancer Research Fund/American Institute for Cancer Research Guideline Is Associated With Better Health-Related Quality of Life Among Chinese Patients With Breast Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/3/article-p286.xmlTrends in Outcomes of Patients With Metastatic Cancer Undergoing Intubation and Mechanical Ventilation: Results of the National Hospital Discharge Survey2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/3/article-p286.pdf2026-04-18Trends in Outcomes of Patients With Metastatic Cancer Undergoing Intubation and Mechanical Ventilation: Results of the National Hospital Discharge Surveyhttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/3/article-p267.xmlPatient-Reported Distress in Myelodysplastic Syndromes and Its Association With Clinical Outcomes: A Retrospective Cohort Study2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/3/article-p267.pdf2026-04-18Patient-Reported Distress in Myelodysplastic Syndromes and Its Association With Clinical Outcomes: A Retrospective Cohort Studyhttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/3/article-p336.xmlGeriatric Oncology Education for the Oncologist is Overdue2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/3/article-p336.pdf2026-04-18Geriatric Oncology Education for the Oncologist is Overdue